Olaine, October 25, 2014, 2014-10-25 12:48 CEST (GLOBE NEWSWIRE) -- An ongoing communication with investors in a manner most convenient for them is a cornerstone of good investor relations, therefore we provide monthly updates on our sales development, deliver timely disclosures and talk to our investors in our quarterly webinars. However, all of that is a distant communication that can not replace relationships that can only be established in live meetings. Therefore we are going on this roadshow, so we not only present our story, but listen to investors and understand what their expectations are,” says Salvis Lapins, Member of the Board of AS „Olainfarm”, Head of company’s Investor relations.
The investors will be introduced to the enclosed presentation, that pays particular attention to company’s operations in Russia and Ukraine as well as to company’s CAPEX programme.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia
Information prepared by:
Salvis Lapins
JSC “Olainfarm”
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv
